Yahoo Web Search

Sign In

Search results

  1. www.ema.europa.euHomepage | European Medicines Agency

    EMA is the EU agency responsible for the evaluation and supervision of medicines for humans and animals. Find information on medicines, COVID-19, events, news and more.

  2. european-union.europa.eu › institutions-law-budgetEuropean Medicines Agency – EMA | European Union

    • Overview
    • What It Does
    • Who Benefits
    Role: EMA guarantees the scientific evaluation, supervision & safety monitoring of human & veterinary medicines in the EU.
    Executive Director: Emer Cooke
    Established in: 1995
    Number of staff:897

    See full list on european-union.europa.eu

    The Agency's main responsibilities are authorising and monitoring medicines in the EU. Companies apply to it for a single marketing authorisation, which is issued by the European Commission. If granted, this enables them to market the medicine concerned throughout the EU and the EEA. Given the wide-ranging scope of the centralised procedure, most g...

    See full list on european-union.europa.eu

    The EMA's work benefits: 1. patients 2. healthcare professionals 3. academics 4. pharmaceutical companies 5. medicine developers 6. health policymakers Through its scientific guidelines, scientific advice programme and incentives, it facilitates research into new medicines and encourages development, thereby translating progress in medical science ...

    See full list on european-union.europa.eu

  3. en.wikipedia.org › wiki › European_Medicines_AgencyEuropean Medicines Agency - Wikipedia

    The European Medicines Agency (EMA) operates as a decentralised scientific agency (as opposed to a regulatory authority) of the European Union (EU) and its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. [8]

    • 897
    • Science. Medicines. Health.
    • 1 January 1995; 28 years ago
    • Amsterdam, Netherlands

  4. Videos

    View all

  5. clinicaldata.ema.europa.eu › web › cdpHome - Clinical Data Publication - clinicaldata.ema.europa.eu

    EMA has resumed clinical data publication for medicines with new active substances that received a CHMP opinion from September 2023 onwards, or were withdrawn before the opinion stage. EMA continues publishing clinical data for COVID-19 medicines. More information is available on EMA's corporate website. 17/04/2024: Clinical data published

  6. People also ask

  1. Searches related to Ema

    ema pratybosema elektronines pratybos
    ema scholarshipemail
    ema education market assistantemail gmail
    ema karterema pratybos mokiniams
  2. People also search for